Degradable hydrogel for retinal tamponade
Award amount
$224,397Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CAMBRIDGE POLYMER GROUP INC
- Proposal award date
- 2017-09-01
- Contract end date
- 2018-08-31
- UEI
- DKJDB8BKRGB3
- Solicitation number
- PA15-269
- Topic code
- NEI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Preventing Pneuomothorax During Transthoracic Lung Biopsy
- Degradable hydrogel for retinal tamponade (phase 2)
- Preventing Pneumothorax During Transthoracic Lung Biopsy
- An injectable biocompatible hydrogel nucleus pulposus replacement
- A Fully Integrated Commercial Multi-sample Multi-Slit Rheometer
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Humidifeye Plug for Dry Eye Disease
- A Novel Therapeutic to Promote Corneal Repair
- Drug Screening Platform in the Light-Responsive Human Eye
- RetiVue EntireEye - A Handheld, High-Resolution, Non-Contact, One Image, Widefield Retinal Screening Camera for Premature and Healthy Newborn Babies
- The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence
Research funding history
13 SBIR/STTR records share this UEI (1997–2022). Reported award amounts total $3,469,773. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation, Department of Commerce